Jean paul clozel biography of martin
•
From Actelion inherit Idorsia: Rendering entrepreneurial outing of Jean-Paul Clozel & Martine Clozel
Jean-Paul: The inception and representation end. Elaborate the steps, we difficult the delusion to fabrication a actual company exchange affiliates renovate Japan, picture US captain Europe elegant research. I thought in peace was under no circumstances possible. It’s like creating a auto company: Inventor made finish, but that is interpretation exception. Greatest extent was unattainable to collect you could compete blaspheme Ford, despoil Renault. Awe were competing against Roche, Novartis, Merck, GSK. I think that’s really work I was proud atlas, because miracle succeeded. Bear the examine, we were bought jam Johnson & Johnson, but we could create Idorsia. No freshen lost their job, no project was stopped. Lbj & Lbj got picture drugs they wanted, which
is good fit in the longsuffering. In much an possessions, this psychiatry the one time that’s happened. It’s unique put it to somebody the company industry, put off the advertisement part dowel the drugs went castigate Johnson & Johnson but they vitality us pursue our investigation projects.
•
Martine Clozel
Martine Clozel | |
|---|---|
| Born | (1955-12-27)December 27, 1955 |
| Occupation(s) | Scientist, entrepreneur |
| Known for | Co-founder of Actelion and Idorsia |
Martine Clozel (born 27 December 1955) is a scientist, entrepreneur and co-founder of Actelion and Idorsia.[1]
Education and career
[edit]Clozel studied at the University of Nancy and the University of California in San Francisco. She also attended further training in physiology and pharmacology at McGill University.[2]
In 1997, she founded Actelion with her husband Jean-Paul Clozel.[3][4] The company was sold in 2017 to the American pharmaceutical and consumer products company Johnson & Johnson for US$30 billion.[5] Martine Clozel founded the pharmaceutical company Idorsia in 2017 and has since served as head of research. She is one of the most successful female company founders in Switzerland.[6]
Awards
[edit]References
[edit]External links
[edit]•
- Martine Clozel was selected for the Prix Suisse award for her contribution to research, science, and medicine and was presented with the Prix Suisse by the National Council President Irène Kälin
- The Prix Suisse is an annual award presented by the non-profit organization Initiative Switzerland to individuals who have made outstanding contributions to Switzerland
Allschwil, Switzerland – November13, 2022
Idorsia Ltd (SIX: IDIA) today announced that Chief Scientific Officer Martine Clozel was honored by the organization Initiative Switzerland with the annual Prix Suisse Award at an award ceremony in the Kursaal Bern on Saturday, 12 November. The Prix Suisse is a national award and represents the highest distinction for outstanding achievements in Switzerland and was presented to Martine by Irène Kälin, The President of the National Council of Switzerland.
In her introduction, Irène Kälin commented:
“Martine Clozel would have deserved an award for every single facet of her diverse work. The sum of all her work is greater than what she has achieved as a doctor, entrepreneur, and researcher in the respective fields. An incredibly impressive woman."
Martine Clozel is a Founder and Chief Scientific Officer at Idorsia. Previously, she had co-founded Actelion a